The company projects plozasiran to generate $2 billion to $3 billion annually in the SHTG market alone, with Phase III studies (SHASTA-3, SHASTA-4, and MUIR 3) expected to complete enrollment this ...
University of Queensland researchers have discovered that nearly 70% of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that ...
5d
Techno-Science on MSNThis prehistoric poisoned arrow shows impressive pharmacological mastery 🏹In 1983, researchers found an antelope femur in Kruger Cave, South Africa. This femur, 7,000 years old, contained arrowheads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results